Dexamethasone release from uniform sized nanoengineered alginate microspheres

Journal of Biomedical Nanotechnology

Volumn 3, Issue 3, 2007, Pages 245-253

  Jayant, R D ^a   Srivastava, R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY BOMBAY   (India)

Author keywords

Alginate; Controlled release; Dexamethasone; LbL.

Indexed keywords

ALGINIC ACID MICROSPHERE; CALCIUM ALGINATE; DEXAMETHASONE; IMMUNOMODULATING AGENT; MICROSPHERE; NANOFILM; POLYELECTROLYTE;

ARTICLE; CHEMICAL STRUCTURE; CONTROLLED RELEASE FORMULATION; DIALYSIS MEMBRANE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; ENCAPSULATION; IMPLANTATION; IN VITRO STUDY; MATERIAL COATING; MICROSCOPY; NANOENGINEERING; NANOMEDICINE; NANOTECHNOLOGY; PARTICLE SIZE; PROCESS OPTIMIZATION; SCANNING ELECTRON MICROSCOPY; SUSTAINED RELEASE FORMULATION; ZETA POTENTIAL;

EID: 45849133794     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2007.039     Document Type: Article

References (50)

1. M. J. McShane, Potential for glucose monitoring with nanoengineered fluorescent biosensors. Diabetes. Technol. Ther. 4, 533 (2002).
2. M. J. McShane, R. J. Russell, M. V. Pishko, and G. L. Coté, Glucose monitoring using implanted fluorescent microspheres. IEEE. Eng. Med. Biol. Mag. 16, 36 (2000).
3. R. J. Russell, M. V. Pishko, C. C. Gefrides, M. J. McShane, and G. L. Coté, A fluorescence-based glucose biosensor using concanavalin A and dextran encapsulated in a poly(ethylene glycol) hydrogel. Anal. Chem. 71, 3126 (1999).
4. J. Q. Brown, R. Srivastava, H. Zhu, and M. J. McShane, Enzymatic fluorescent microsphere glucose sensors: Evaluation of response under dynamic conditions. Diabetes Technol. Ther. 8, 288 (2000).
5. B. D. Ratner, A. S. Hoffman, F. J. Shoen, and J. E. Lemons, Biomaterials Science: An Introduction to Materials in Medicine, Academic press, New York (1996).
6. S. L. Robbins and V. Kumar (eds.), Basic Pathology, Saunders, Philadelphia (1997).
7. A. A. Sharkawy, B. Klitzman, G. A. Truskey, and W. M. Reichert, Engineering the tissue which encapsulates subcutaneous implants. II. Plasma-tissue exchange properties. J. Biomed. Mater. Res. 40, 586 (1998).
8. A. A. Sharkawy, B. Klitzman, G. A. Truskey, and W. M. Reichert, Engineering the tissue which encapsulates subcutaneous implants. I. Diffusion properties. J. Biomed. Mater. Res. 37, 401 (1997).
9. M. Schlosser and M. Ziegler (eds.), Biocompatibility of Active Implantable Devices, Wiley, Chichester, New York (1997).
10. A. A. Sharkawy, B. Klitzman, G. A. Truskey, and W. M. Reichert, Engineering the tissue which encapsulates subcutaneous implants. III. Effective tissue response times. J. Biomed. Mater. Res. 40, 598 (1998).
11. B. Noerr, Dexamethasone. Neonatal Network 16, 67 (1997).
12. T. M. Gross and J. J. Mastrototaro, Efficacy and reliability of the continuous glucose monitoring system. Diabetes Technol. Ther. 2(Suppl. 1) S19 (2000).
13. P. U. Abel, T. V. Woedtke, Biosensors for in vivo glucose measurement: Can we cross the experimental stage. Biosens. Bioelectron. 17, 1059 (2002).
14. P. U. Abel and V. T. Woedtke, Biosensors for glycaemic control. Sensor Reviews 21, 297 (2001).
15. L. C. Clark, Jr., R. B. Spokane, M. M. Homan, R. Sudan, and M. Miller, Long-term stability of electroenzymatic glucose sensors implanted in mice. An update. ASAIO Trans. 34, 259 (1988).
16. L. C. Clark, Jr. and C. A. Duggan, Implanted electroenzymatic glucose sensors. Diabetes Care 5, 174 (1982).
17. N. Pauletto, J. G. Silver, and H. Ladava, Nonsteroidal anti-inflammatory agents: Potential modifiers of periodontal disease progression. J. Can. Dent. Assoc. 63, 824 (1997).
18. N. Goulding and R. Flower (eds.), Glucocorticoids, Birkhauser Verlag, Boston (2001).
19. T. Hickey, D. Kreutzer, D. J. Burgess, and F. Moussy, In-vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J. Biomed. Mater. Res. 61, 180 (2002).
20. J. G. Hardman, L. E. Limbird, P. B. Molinoff, R. W. Ruddon and A. G. Gilman (eds.), Goodman and Gilman's the Pharmacological Basis of Therapeutics, McGraw-Hill, Texas (1996).
21. N. Pargaonkar, Y. M. Lvov, N. Li, J. H. Steenekamp, and M. M. de Villiers, Controlled release of dexamethasone from microcapsules produced by polyelectrolyte layer-by-layer nanoassembly. Pharm. Res. 22, 826 (2005).
22. D. J. Burgess and A. J. Hickey, Microsphere Technology and Applications, Encyclopedia of Pharmaceutical Technology, edited by J. Swarbrick and J. C. Boylan, Marcel Dekker, New york (1994), Vol. 1, pp. 1-29.
23. A. F. Kydonieus (ed.), Controlled Release Technologies: Methods, Theory, and Applications, I, CRC Press, New York, Marcel Dekker (1980).
24. D. Gensheimer, A review of calcium alginates. Ostomy Wound Manage 39, 34 (1993).
25. L. W. Chan and P. W. Heng, Effects of poly(vinylpyrrolidone) and ethylcellulose on alginate microspheres prepared by emulsification. J. Microencapsul. 15, 409 (1998).
26. B. L. Strand, O. Gaserod, B. Kulseng, T. Espevik, and G. Skjak-Baek, Alginate-polylysine-alginate microcapsules: Effect of size reduction on capsule properties. J. Microencapsul. 19, 615 (2002).
27. T. Okano, A. kikuchi, M. Kawabuchi, M. Sugihara, and Y. Sakurai, Pulsed dextran release from calcium-alginate gel beads. J. Controlled Release 47, 21 (1997).
28. P. De Vos, B. De Haan, and R. Van Schilfgaarde, Effect of the alginate composition on the biocompatibility of alginate-polylysine microcapsules. Biomaterials 18, 273 (1997).
29. S. Schneider, P. J. Feilen, O. Kraus, T. Haase, T. A. Sagban, H. A. Lehr, J. Beyer, R. Pommersheim, and M. M. Weber, Biocompatibility of alginates for grafting: Impact of alginate molecular weight. Artif. Cells Blood Substit. Immobil. Biotechnol. 31, 383 (2003).
30. A. Gaumann, M. Laudes, B. Jacob, R. Pommersheim, C. Laue, W. Vogt, and J. Schrezenmeir, Xenotransplantation of parathyroids in rats using barium-alginate and polyacrylic acid multilayer microcapsules. Exp. Toxicol. Pathol. 53, 35 (2001).
31. R. Srivastava, J. Q. Brown, H. Zhu, and M. J. McShane, Stable encapsulation of active enzyme by application of multilayer nanofilm coatings to alginate microspheres. Macromol. Biosci. 5, 717 ( 2005).
32. R. Srivastava, J. Q. Brown, H. Zhu, and M. J. McShane, Stabilization of glucose oxidase in alginate microspheres with photoreactive diazoresin nanofilm coatings. Biotechnol. Bioeng. 91, 124 (2005).
33. R. Srivastava and M. J. McShane, Application of self-assembled ultra-thin film coatings to stabilize macromolecule encapsulation in alginate microspheres. J. Microencapsul. 22, 397 (2005).
34. J. R. Robinson and V. H. Lee (eds.), Controlled drug delivery: Fundamentals and applications, Marcel Dekker Inc., New york (1992).
35. P. Lee, Initial concentration distribution as a mechanism for regulating drug release from diffusion controlled and surface erosion controlled matrix systems. J. Controlled Release 4, 1 (1986).
36. T. Coviello, P. Matricardi, and F. Alhaique, Drug delivery strategies using polysaccharidic gels. Expert Opin. Drug Deliv. 3, 395 ( 2006).
37. J. T. Garcia, J. B, Farina, O. Munguia, and M. Llabres, Comparative degradation study of biodegradable microspheres of poly(DL lactideco-glycolide) with poly(ethylene glycol) derivatives. J Microencapsulation 16, 83 (1999).
38. R. Gref, Y. Minamitake, M. T. Peracchia, V. Trubetskoy, V. Torchilin, and R. Langer, Biodegradable long-circulating polymeric nanospheres. Science 263, 1600 (1994)
39. S. Einmahl, M. Zignani, E. Varesio, J. Heller, J. L. Veuthey, C. Tabatabay, and R. Gurny, Concomitant and controlled release of dexamethasone and 5-fluorouracil from poly(ortho ester). Int. J. Pharm. 185, 189 (1999).
40. G. Decher and J. B. Schlenoff (eds.), Multilayer thin films: Sequential assembly of nanocomposite materails, Wiley-VCH, Germany (2003).
41. H. Zhu, R. Srivastava, and M. J. McShane, Spontaneous loading of positively charged macromolecules into alginate-templated polyelectrolyte multilayer microcapsules. Biomacromolecules 6, 2221 (2005).
42. P. T. Hammond, Form and function in multilayer assembly: New applications at the nanoscale. Adv. Mater. 16, 1271 (2004).
43. B. G. De Geest, C. Dejugnat, E. Verhoeven, G. B. Sukhorukov, A. M. Jonas, J. Plain, J. Demeester, and S. C. De Smedt, Layer-by-layer coating of degradable microgels for pulsed drug delivery. J. Controlled Release 116, 159 (2006).
44. G. Z. Sauerbrey, Verwendung von Schwingquarzen zur Wägung dünner Schichten und zur Mikrowaage. Z. Phys. Verhandl. 155, 206 (1959).
45. Y. Lvov, K. Ariga, I. Ichinose, and T. Kunitake, Assembly of multicomponent protein films by means of electrostatic layer-by-layer adsorption. J. Am. Chem. Soc. 117, 6117 (1995)
46. F. Caruso, K. Niikura, D. N. Furlong, and Y. Okahata, Ultrathin multilayer polyelectrolyte films on gold: Construction and thickness determination. Langmuir 13, 3422 (1997).
47. Z. Rahman, K. Kohli, R. K. Khar, M. Ali, N. A. Charon, and A. A. Shamsher, Characterization of 5-fluorouracil microspheres for colonic delivery. AAPS PharmSciTech. 7, E-47 (2006).
48. R. Gifford, J. J. Kehoe, S. L. Barnes, B. A. Kornilayev, M. A. Alterman, and G. S. Wilson, Protein interactions with subcutaneously implanted biosensors. Biomaterials 27, 2587 (2006).
49. T. Higuchi, Mechanism of sustained-action medication - Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 52, 1145 (1963).
50. R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri, and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers. Int. J. Pharm. 15, 25 (1983).